Aurantiamide
Aurantiamide exhibits anti-cancer, anti-inflammatory, and antinociceptive properties. Its mechanisms include blocking autophagic flux to suppress glioma growth and inhibiting NF-κB, JNK, and p38 pathways to counteract neuroinflammation. This small molecule is a useful research tool for neuroscience and oncology studies in both in vitro and in vivo models.
Product Specifications
CAS Number
58115-31-4
Product Name Alternative
P38 MAPK, p38, p38MAPK, TMC-58B, NFκB, NF-kB, NFkB, NF-κB, Inhibitor, inhibit, antioxidant, anti-inflammatory, antiplatelet, antitumor, Aurantiamide
Field of Research
Cell Biology, Signal Transduction
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.2 mM) ; DMSO:100 mg/mL (248.45 mM)
Smiles
OC[C@H] (Cc1ccccc1) NC (=O) [C@H] (Cc1ccccc1) NC (=O) c1ccccc1
Molecular Formula
C25H26N2O3
Molecular Weight
402.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Aconitase 1 (ACO1, ACONS, IREB1, IREBP, IREBP1, IRP1, Aconitate Hydratase, Citrate Hydro-lyase, Ferritin Repressor Protein, Iron Regulatory Protein 1, Iron-responsive Element Binding Protein 1)
Aconitase 1 (ACO1, ACONS, IREB1, IREBP, IREBP1, IRP1, Aconitate Hydratase, Citrate Hydro-lyase, Ferritin Repressor Protein, Iron Regulatory Protein 1, Iron-responsive Element Binding Protein 1)
